169 related articles for article (PubMed ID: 30739717)
1. Gait Speed and Grip Strength Are Associated With Dropping Out of the Liver Transplant Waiting List.
Kulkarni SS; Chen H; Josbeno DA; Schmotzer A; Hughes C; Humar A; Sood P; Rachakonda V; Dunn MA; Tevar AD
Transplant Proc; 2019 Apr; 51(3):794-797. PubMed ID: 30739717
[TBL] [Abstract][Full Text] [Related]
2. Frailty as Tested by Gait Speed is an Independent Risk Factor for Cirrhosis Complications that Require Hospitalization.
Dunn MA; Josbeno DA; Tevar AD; Rachakonda V; Ganesh SR; Schmotzer AR; Kallenborn EA; Behari J; Landsittel DP; DiMartini AF; Delitto A
Am J Gastroenterol; 2016 Dec; 111(12):1768-1775. PubMed ID: 27575708
[TBL] [Abstract][Full Text] [Related]
3. Association of Frailty and Sex With Wait List Mortality in Liver Transplant Candidates in the Multicenter Functional Assessment in Liver Transplantation (FrAILT) Study.
Lai JC; Ganger DR; Volk ML; Dodge JL; Dunn MA; Duarte-Rojo A; Kappus MR; Rahimi RS; Ladner DP; Boyarsky B; McAdams-DeMarco M; Segev DL; McCulloch CE; Verna EC
JAMA Surg; 2021 Mar; 156(3):256-262. PubMed ID: 33377947
[TBL] [Abstract][Full Text] [Related]
4. Time of Dropout From the Liver Transplant List in Patients With Hepatocellular Carcinoma: Clinical Behavior According to Tumor Characteristics and Severity of Liver Disease.
Salvalaggio PR; Felga GE; Guardia BD; Almeida MD; Pandullo FL; Matielo CE; Evangelista A; Curvelo L; Rocco RA; Alves JA; Meirelles RF; Filho SP; de Rezende MB; Pedroso PT; Diaz LG; Rusi MB; Viveiros MM; Neves DB
Transplant Proc; 2016 Sep; 48(7):2319-2322. PubMed ID: 27742288
[TBL] [Abstract][Full Text] [Related]
5. Liver Transplant Waitlist Outcomes and the Allocation of Hepatocellular Carcinoma Model for End-Stage Liver Disease Exception Points at a Low-Volume Center.
Tan EK; Goh BKP; Lee SY; Krishnamoorthy TL; Tan CK; Jeyaraj PR
Transplant Proc; 2018 Dec; 50(10):3564-3570. PubMed ID: 30577239
[TBL] [Abstract][Full Text] [Related]
6. Development of a novel frailty index to predict mortality in patients with end-stage liver disease.
Lai JC; Covinsky KE; Dodge JL; Boscardin WJ; Segev DL; Roberts JP; Feng S
Hepatology; 2017 Aug; 66(2):564-574. PubMed ID: 28422306
[TBL] [Abstract][Full Text] [Related]
7. Association Between Liver Transplant Wait-list Mortality and Frailty Based on Body Mass Index.
Haugen CE; McAdams-DeMarco M; Verna EC; Rahimi RS; Kappus MR; Dunn MA; Volk ML; Gurakar A; Duarte-Rojo A; Ganger DR; O'Leary JG; Ladner D; Garonzik-Wang J; Segev DL; Lai JC
JAMA Surg; 2019 Dec; 154(12):1103-1109. PubMed ID: 31509169
[TBL] [Abstract][Full Text] [Related]
8. Quality of life in liver transplant candidates: frailty is a better indicator than severity of liver disease.
Derck JE; Thelen AE; Cron DC; Friedman JF; Gerebics AD; Englesbe MJ; Sonnenday CJ
Transplantation; 2015 Feb; 99(2):340-4. PubMed ID: 25606782
[TBL] [Abstract][Full Text] [Related]
9. Frailty is independently associated with increased hospitalisation days in patients on the liver transplant waitlist.
Sinclair M; Poltavskiy E; Dodge JL; Lai JC
World J Gastroenterol; 2017 Feb; 23(5):899-905. PubMed ID: 28223735
[TBL] [Abstract][Full Text] [Related]
10. Outcomes for liver transplant candidates listed with low model for end-stage liver disease score.
Kwong AJ; Lai JC; Dodge JL; Roberts JP
Liver Transpl; 2015 Nov; 21(11):1403-9. PubMed ID: 26289624
[TBL] [Abstract][Full Text] [Related]
11. Model for End-Stage Liver Disease (MELD) score system to evaluate patients with viral hepatitis on the waiting list: better than the Child-Turcotte-Pugh (CTP) system?
Cuomo O; Perrella A; Arenga G
Transplant Proc; 2008; 40(6):1906-9. PubMed ID: 18675085
[TBL] [Abstract][Full Text] [Related]
12. Frailty as Tested by Gait Speed Is a Risk Factor for Liver Transplant Respiratory Complications.
Salim TI; Nestlerode LC; Lucatorto EL; Wasserman TL; Din HA; Landsittel DP; Tevar AD; Johnson JT; Duarte-Rojo A; Dunn MA
Am J Gastroenterol; 2020 Jun; 115(6):859-866. PubMed ID: 32235146
[TBL] [Abstract][Full Text] [Related]
13. ['Will I receive a liver transplant in time?'; chance of survival of patients on the liver transplant waiting list].
Tieleman M; van den Berg AP; van Hoek B; Polak WG; Dubbeld J; Porte RJ; Konijn C; de Man RA; Hanssen BE; Metselaar HJ
Ned Tijdschr Geneeskd; 2018; 162():D2159. PubMed ID: 29519259
[TBL] [Abstract][Full Text] [Related]
14. Dynamic changes in MELD score not only predict survival on the waiting list but also overall survival after liver transplantation.
Györi GP; Silberhumer GR; Zehetmayer S; Kern B; Hetz H; Soliman T; Steininger R; Mühlbacher F; Berlakovich GA
Transpl Int; 2012 Sep; 25(9):935-40. PubMed ID: 22775308
[TBL] [Abstract][Full Text] [Related]
15. Impact of frailty on mortality after transcatheter aortic valve implantation.
Kleczynski P; Dziewierz A; Bagienski M; Rzeszutko L; Sorysz D; Trebacz J; Sobczynski R; Tomala M; Stapor M; Dudek D
Am Heart J; 2017 Mar; 185():52-58. PubMed ID: 28267475
[TBL] [Abstract][Full Text] [Related]
16. [The Argentine experience with human immune deficiency virus positive patients in the waiting list for liver transplantation: preliminary analysis].
Villamil A; Bisignano L; Orozco F; Bandi JC; Barcán L; McCormack L; Gondolesi G; Santibañes Ed; Gadano A
Acta Gastroenterol Latinoam; 2013 Jun; 43(2):113-20. PubMed ID: 23940911
[TBL] [Abstract][Full Text] [Related]
17. Beta-blockers and physical frailty in patients with end-stage liver disease.
Kuo SZ; Lizaola B; Hayssen H; Lai JC
World J Gastroenterol; 2018 Sep; 24(33):3770-3775. PubMed ID: 30197482
[TBL] [Abstract][Full Text] [Related]
18. Testing liver allocation in São Paulo, Brazil: the relationship of model for end-stage liver disease implementation with a reduction in waiting-list mortality.
Salvalaggio PR; Afonso RC; Pereira LA; Ferraz-Neto BH
Transplant Proc; 2012 Oct; 44(8):2283-5. PubMed ID: 23026574
[TBL] [Abstract][Full Text] [Related]
19. A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list.
Vitale A; Volk ML; De Feo TM; Burra P; Frigo AC; Ramirez Morales R; De Carlis L; Belli L; Colledan M; Fagiuoli S; Rossi G; Andorno E; Baccarani U; Regalia E; Vivarelli M; Donataccio M; Cillo U;
J Hepatol; 2014 Feb; 60(2):290-7. PubMed ID: 24161408
[TBL] [Abstract][Full Text] [Related]
20. Dropout rate from the liver transplant waiting list because of hepatocellular carcinoma progression in hepatitis C virus-infected patients treated with direct-acting antivirals.
Zanetto A; Shalaby S; Vitale A; Mescoli C; Ferrarese A; Gambato M; Franceschet E; Germani G; Senzolo M; Romano A; Angeli P; Rugge M; Farinati F; Forton DM; Cillo U; Burra P; Russo FP
Liver Transpl; 2017 Sep; 23(9):1103-1112. PubMed ID: 28544587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
